PIK3CD and gastric cancer: Furthermore, we uncover that PIK3CD overexpression in GC may be induced by the activation of the pro‐inflammatory IL2‐JAK3‐STAT5 signaling axis and PIK3CD may serve as an effective therapeutic target for GC treatment.